|
1
|
Large recurrent microdeletions associated with schizophrenia.
|
Nature
|
2008
|
20.25
|
|
2
|
Identification of loci associated with schizophrenia by genome-wide association and follow-up.
|
Nat Genet
|
2008
|
10.52
|
|
3
|
Common variants conferring risk of schizophrenia.
|
Nature
|
2009
|
10.37
|
|
4
|
A genome-wide investigation of SNPs and CNVs in schizophrenia.
|
PLoS Genet
|
2009
|
5.01
|
|
5
|
Disruption of the neurexin 1 gene is associated with schizophrenia.
|
Hum Mol Genet
|
2008
|
4.78
|
|
6
|
Identifying depression in primary care: a comparison of different methods in a prospective cohort study.
|
BMJ
|
2003
|
3.78
|
|
7
|
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.
|
Int J Neuropsychopharmacol
|
2010
|
2.74
|
|
8
|
The diagnosis and treatment of generalized anxiety disorder.
|
Dtsch Arztebl Int
|
2013
|
2.73
|
|
9
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
|
World J Biol Psychiatry
|
2008
|
2.64
|
|
10
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.
|
World J Biol Psychiatry
|
2007
|
2.40
|
|
11
|
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.
|
Arch Gen Psychiatry
|
2009
|
2.17
|
|
12
|
Hippocampal changes in patients with a first episode of major depression.
|
Am J Psychiatry
|
2002
|
2.15
|
|
13
|
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
|
J Clin Psychiatry
|
2009
|
2.09
|
|
14
|
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
|
Arch Gen Psychiatry
|
2007
|
2.05
|
|
15
|
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
|
Neuroimage
|
2007
|
2.03
|
|
16
|
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
|
Brain
|
2005
|
2.03
|
|
17
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
|
World J Biol Psychiatry
|
2005
|
1.98
|
|
18
|
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness.
|
Am J Psychiatry
|
2011
|
1.94
|
|
19
|
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection.
|
Neuroimage
|
2004
|
1.84
|
|
20
|
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI.
|
J Neurosci
|
2011
|
1.81
|
|
21
|
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease.
|
Arch Neurol
|
2005
|
1.75
|
|
22
|
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
|
Arch Gen Psychiatry
|
2008
|
1.75
|
|
23
|
Factor structure and external validity of the PANSS revisited.
|
Schizophr Res
|
2005
|
1.74
|
|
24
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
|
World J Biol Psychiatry
|
2012
|
1.69
|
|
25
|
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
|
World J Biol Psychiatry
|
2003
|
1.66
|
|
26
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.
|
World J Biol Psychiatry
|
2002
|
1.63
|
|
27
|
Depression-related variation in brain morphology over 3 years: effects of stress?
|
Arch Gen Psychiatry
|
2008
|
1.61
|
|
28
|
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
|
World J Biol Psychiatry
|
2010
|
1.61
|
|
29
|
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
|
Biol Psychiatry
|
2006
|
1.57
|
|
30
|
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects.
|
Biol Psychiatry
|
2003
|
1.55
|
|
31
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
|
World J Biol Psychiatry
|
2012
|
1.55
|
|
32
|
Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study.
|
J Psychiatry Neurosci
|
2008
|
1.53
|
|
33
|
Multivariate network analysis of fiber tract integrity in Alzheimer's disease.
|
Neuroimage
|
2006
|
1.52
|
|
34
|
Response and remission criteria in major depression--a validation of current practice.
|
J Psychiatr Res
|
2010
|
1.52
|
|
35
|
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients.
|
Am J Psychiatry
|
2002
|
1.51
|
|
36
|
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.
|
Int J Psychiatry Clin Pract
|
2012
|
1.49
|
|
37
|
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.
|
World J Biol Psychiatry
|
2013
|
1.48
|
|
38
|
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.
|
J Clin Psychiatry
|
2004
|
1.48
|
|
39
|
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.
|
Arch Gen Psychiatry
|
2010
|
1.46
|
|
40
|
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
|
Brain
|
2004
|
1.45
|
|
41
|
Progression of corpus callosum atrophy in Alzheimer disease.
|
Arch Neurol
|
2002
|
1.44
|
|
42
|
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
|
J Clin Psychopharmacol
|
2003
|
1.43
|
|
43
|
Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project.
|
J Clin Psychiatry
|
2010
|
1.41
|
|
44
|
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
|
Arch Neurol
|
2002
|
1.41
|
|
45
|
Enlargement of the amygdala in patients with a first episode of major depression.
|
Biol Psychiatry
|
2002
|
1.38
|
|
46
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.
|
World J Biol Psychiatry
|
2002
|
1.38
|
|
47
|
Ethical aspects of publishing.
|
World J Biol Psychiatry
|
2006
|
1.37
|
|
48
|
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification.
|
Schizophr Bull
|
2011
|
1.36
|
|
49
|
Reduced hippocampal volume correlates with executive dysfunctioning in major depression.
|
J Psychiatry Neurosci
|
2006
|
1.35
|
|
50
|
Early detection and secondary prevention of psychosis: facts and visions.
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
1.34
|
|
51
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.
|
World J Biol Psychiatry
|
2013
|
1.34
|
|
52
|
Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups.
|
Gen Hosp Psychiatry
|
2004
|
1.34
|
|
53
|
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.
|
Depress Anxiety
|
2007
|
1.32
|
|
54
|
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
|
Ann Neurol
|
2002
|
1.29
|
|
55
|
White matter microstructure underlying default mode network connectivity in the human brain.
|
Neuroimage
|
2009
|
1.29
|
|
56
|
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
|
Am J Psychiatry
|
2002
|
1.28
|
|
57
|
Personality and attempted suicide. Analysis of anger, aggression and impulsivity.
|
J Psychiatr Res
|
2009
|
1.26
|
|
58
|
Is the PANSS used correctly? a systematic review.
|
BMC Psychiatry
|
2011
|
1.22
|
|
59
|
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.
|
Schizophr Res
|
2010
|
1.22
|
|
60
|
Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression.
|
Biol Psychiatry
|
2010
|
1.22
|
|
61
|
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
|
J Clin Psychiatry
|
2007
|
1.19
|
|
62
|
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
|
J Clin Psychiatry
|
2002
|
1.19
|
|
63
|
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
|
Am J Psychiatry
|
2003
|
1.19
|
|
64
|
Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims.
|
Biol Psychiatry
|
2004
|
1.17
|
|
65
|
The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers.
|
J Neurosci
|
2011
|
1.14
|
|
66
|
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
|
J Affect Disord
|
2008
|
1.13
|
|
67
|
Childhood stress, serotonin transporter gene and brain structures in major depression.
|
Neuropsychopharmacology
|
2010
|
1.12
|
|
68
|
Functional connectivity of emotional processing in depression.
|
J Affect Disord
|
2011
|
1.11
|
|
69
|
Reduced early auditory evoked gamma-band response in patients with schizophrenia.
|
Biol Psychiatry
|
2009
|
1.11
|
|
70
|
Failure to replicate effect of Kibra on human memory in two large cohorts of European origin.
|
Am J Med Genet B Neuropsychiatr Genet
|
2008
|
1.11
|
|
71
|
Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI.
|
Neuroimage
|
2005
|
1.11
|
|
72
|
Screening for depression in primary care: will one or two items suffice?
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
1.10
|
|
73
|
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.
|
Schizophr Bull
|
2010
|
1.10
|
|
74
|
Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study.
|
Neuroimage
|
2007
|
1.10
|
|
75
|
Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study.
|
J Psychiatr Res
|
2005
|
1.10
|
|
76
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
|
World J Biol Psychiatry
|
2006
|
1.10
|
|
77
|
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
|
Int Clin Psychopharmacol
|
2009
|
1.09
|
|
78
|
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia.
|
Hum Mol Genet
|
2010
|
1.08
|
|
79
|
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.
|
Arch Gen Psychiatry
|
2004
|
1.08
|
|
80
|
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
|
Int Clin Psychopharmacol
|
2007
|
1.07
|
|
81
|
A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits.
|
Biol Psychiatry
|
2003
|
1.07
|
|
82
|
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
|
Schizophr Res
|
2007
|
1.07
|
|
83
|
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
|
J Clin Psychiatry
|
2010
|
1.07
|
|
84
|
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
|
J Neurol
|
2006
|
1.07
|
|
85
|
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
|
World J Biol Psychiatry
|
2011
|
1.06
|
|
86
|
Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
|
Am J Med Genet B Neuropsychiatr Genet
|
2010
|
1.05
|
|
87
|
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study.
|
Cereb Cortex
|
2006
|
1.05
|
|
88
|
Prediction of treatment response in major depression: integration of concepts.
|
J Affect Disord
|
2006
|
1.04
|
|
89
|
Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making.
|
Neuroimage
|
2008
|
1.04
|
|
90
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
|
World J Biol Psychiatry
|
2002
|
1.04
|
|
91
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
|
World J Biol Psychiatry
|
2011
|
1.04
|
|
92
|
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
|
Biol Psychiatry
|
2003
|
1.04
|
|
93
|
Associations between trait impulsivity and prepotent response inhibition.
|
J Clin Exp Neuropsychol
|
2012
|
1.04
|
|
94
|
The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia.
|
Schizophr Res
|
2003
|
1.04
|
|
95
|
White matter microstructure in relation to education in aging and Alzheimer's disease.
|
J Alzheimers Dis
|
2009
|
1.03
|
|
96
|
Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis.
|
Schizophr Res
|
2010
|
1.03
|
|
97
|
Placebo-controlled studies in depression: necessary, ethical and feasible.
|
Eur Arch Psychiatry Clin Neurosci
|
2003
|
1.03
|
|
98
|
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.
|
Br J Psychiatry
|
2009
|
1.02
|
|
99
|
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
1.02
|
|
100
|
Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
|
J Alzheimers Dis
|
2011
|
1.02
|
|
101
|
Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.
|
World J Biol Psychiatry
|
2009
|
1.01
|
|
102
|
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity.
|
Neuropsychopharmacology
|
2002
|
1.01
|
|
103
|
German research network on schizophrenia-bridging the gap between research and care.
|
Eur Arch Psychiatry Clin Neurosci
|
2003
|
1.01
|
|
104
|
Predictors of relapse in the year after hospital discharge among patients with schizophrenia.
|
Psychiatr Serv
|
2012
|
1.00
|
|
105
|
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
|
Neurobiol Aging
|
2006
|
1.00
|
|
106
|
Electroconvulsive therapy and its different indications.
|
Dialogues Clin Neurosci
|
2008
|
0.99
|
|
107
|
Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims.
|
Int J Neuropsychopharmacol
|
2007
|
0.99
|
|
108
|
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
|
World J Biol Psychiatry
|
2004
|
0.99
|
|
109
|
Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder.
|
Psychiatry Res
|
2007
|
0.99
|
|
110
|
Evaluation of the German WPA "program against stigma and discrimination because of schizophrenia--Open the Doors": results from representative telephone surveys before and after three years of antistigma interventions.
|
Schizophr Res
|
2007
|
0.99
|
|
111
|
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
|
Eur Neuropsychopharmacol
|
2007
|
0.99
|
|
112
|
Should the PANSS be rescaled?
|
Schizophr Bull
|
2009
|
0.99
|
|
113
|
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
|
Wien Med Wochenschr
|
2010
|
0.99
|
|
114
|
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
|
J Nucl Med
|
2005
|
0.98
|
|
115
|
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
|
Schizophr Res
|
2003
|
0.98
|
|
116
|
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
0.97
|
|
117
|
Regional networks underlying interhemispheric connectivity: an EEG and DTI study in healthy ageing and amnestic mild cognitive impairment.
|
Hum Brain Mapp
|
2009
|
0.97
|
|
118
|
Reliability and plasticity of response inhibition and interference control.
|
Brain Cogn
|
2012
|
0.96
|
|
119
|
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
|
Eur Arch Psychiatry Clin Neurosci
|
2008
|
0.96
|
|
120
|
Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.
|
Schizophr Bull
|
2011
|
0.96
|
|
121
|
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
|
Int Clin Psychopharmacol
|
2010
|
0.96
|
|
122
|
Functional neural correlates of psychometric schizotypy: an fMRI study of antisaccades.
|
Psychophysiology
|
2011
|
0.96
|
|
123
|
Amygdala volume and depressive symptoms in patients with borderline personality disorder.
|
Biol Psychiatry
|
2006
|
0.96
|
|
124
|
Action blind: disturbed self-other integration in schizophrenia.
|
Neuropsychologia
|
2012
|
0.96
|
|
125
|
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.
|
Schizophr Res
|
2010
|
0.96
|
|
126
|
Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease.
|
Psychophysiology
|
2002
|
0.96
|
|
127
|
Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.96
|
|
128
|
Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment.
|
J Alzheimers Dis
|
2010
|
0.95
|
|
129
|
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
0.95
|
|
130
|
Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder.
|
Int J Psychophysiol
|
2006
|
0.95
|
|
131
|
Treatment Response in First-episode Schizophrenia.
|
Clin Psychopharmacol Neurosci
|
2012
|
0.95
|
|
132
|
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.
|
Am J Psychiatry
|
2003
|
0.95
|
|
133
|
The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.
|
Hum Brain Mapp
|
2010
|
0.95
|
|
134
|
Antidepressants and driving ability: results from a clinical study.
|
J Clin Psychiatry
|
2006
|
0.94
|
|
135
|
Orbitofrontal volume reductions during emotion recognition in patients with major depression.
|
J Psychiatry Neurosci
|
2010
|
0.94
|
|
136
|
HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers.
|
Am J Med Genet B Neuropsychiatr Genet
|
2007
|
0.94
|
|
137
|
Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis.
|
Schizophr Res
|
2010
|
0.94
|
|
138
|
Cognitive functioning in euthymic bipolar I and bipolar II patients.
|
Bipolar Disord
|
2008
|
0.94
|
|
139
|
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
|
J Psychiatr Res
|
2005
|
0.94
|
|
140
|
Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
|
Arch Gen Psychiatry
|
2009
|
0.94
|
|
141
|
Neuronal correlates of emotional processing in patients with major depression.
|
World J Biol Psychiatry
|
2009
|
0.93
|
|
142
|
Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course.
|
Psychiatry Res
|
2008
|
0.93
|
|
143
|
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study.
|
J Psychiatr Res
|
2010
|
0.93
|
|
144
|
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors.
|
Eur Arch Psychiatry Clin Neurosci
|
2014
|
0.93
|
|
145
|
Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
|
J Psychiatr Res
|
2005
|
0.93
|
|
146
|
Decreased T cellular immune response in schizophrenic patients.
|
J Psychiatr Res
|
2006
|
0.93
|
|
147
|
Outcomes of 1014 naturalistically treated inpatients with major depressive episode.
|
Eur Neuropsychopharmacol
|
2010
|
0.93
|
|
148
|
Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission.
|
Schizophr Res
|
2010
|
0.92
|
|
149
|
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
|
Schizophr Res
|
2009
|
0.92
|
|
150
|
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
0.92
|
|
151
|
Auditory cortex and anterior cingulate cortex sources of the early evoked gamma-band response: relationship to task difficulty and mental effort.
|
Neuropsychologia
|
2007
|
0.92
|
|
152
|
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2007
|
0.92
|
|
153
|
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.
|
Eur Arch Psychiatry Clin Neurosci
|
2014
|
0.92
|
|
154
|
Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene.
|
J Affect Disord
|
2006
|
0.91
|
|
155
|
Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients.
|
Neuropsychobiology
|
2011
|
0.91
|
|
156
|
Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
|
Brain
|
2007
|
0.91
|
|
157
|
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.
|
Biol Psychiatry
|
2005
|
0.91
|
|
158
|
Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression.
|
Am J Med Genet B Neuropsychiatr Genet
|
2008
|
0.90
|
|
159
|
DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression.
|
PLoS One
|
2012
|
0.90
|
|
160
|
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?
|
Eur Neuropsychopharmacol
|
2011
|
0.89
|
|
161
|
Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system?
|
Arch Suicide Res
|
2007
|
0.89
|
|
162
|
Cincinnati criteria for mixed mania and suicidality in patients with acute mania.
|
Compr Psychiatry
|
2003
|
0.89
|
|
163
|
Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.
|
Expert Opin Drug Saf
|
2010
|
0.89
|
|
164
|
Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication.
|
Clin EEG Neurosci
|
2007
|
0.89
|
|
165
|
Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses.
|
J Psychiatr Res
|
2007
|
0.89
|
|
166
|
Treatment of depression with atypical features: a meta-analytic approach.
|
Psychiatry Res
|
2006
|
0.89
|
|
167
|
Methylphenidate effects on neural activity during response inhibition in healthy humans.
|
Cereb Cortex
|
2012
|
0.89
|
|
168
|
No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.
|
Ann Gen Psychiatry
|
2013
|
0.89
|
|
169
|
Clinical predictors of response and remission in inpatients with depressive syndromes.
|
J Affect Disord
|
2011
|
0.89
|
|
170
|
Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.
|
J Psychopharmacol
|
2011
|
0.89
|
|
171
|
The impact of antipsychotics on psychomotor performance with regards to car driving skills.
|
J Clin Psychopharmacol
|
2004
|
0.88
|
|
172
|
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
|
J Clin Psychiatry
|
2010
|
0.88
|
|
173
|
Neuropsychological impairments predict the clinical course in schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2008
|
0.88
|
|
174
|
Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
0.88
|
|
175
|
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.
|
Psychiatry Res
|
2007
|
0.88
|
|
176
|
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
|
J Clin Psychiatry
|
2008
|
0.88
|
|
177
|
Recent progress in pharmacological and non-pharmacological treatment options of major depression.
|
Curr Pharm Des
|
2006
|
0.88
|
|
178
|
SNAP-25 genotype influences NAA/Cho in left hippocampus.
|
J Neural Transm (Vienna)
|
2008
|
0.88
|
|
179
|
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
|
J Psychiatr Res
|
2009
|
0.88
|
|
180
|
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.88
|
|
181
|
P300 subcomponents in obsessive-compulsive disorder.
|
J Psychiatr Res
|
2002
|
0.87
|
|
182
|
Attitude towards adherence in patients with schizophrenia at discharge.
|
J Psychiatr Res
|
2009
|
0.87
|
|
183
|
A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.
|
Neuropsychopharmacology
|
2006
|
0.87
|
|
184
|
Psychosis during treatment with isotretinoin.
|
Ther Adv Psychopharmacol
|
2013
|
0.87
|
|
185
|
GABAA receptors as targets for novel anxiolytic drugs.
|
World J Biol Psychiatry
|
2006
|
0.87
|
|
186
|
Safety evaluation of zotepine for the treatment of schizophrenia.
|
Expert Opin Drug Saf
|
2010
|
0.87
|
|
187
|
The effects of methylphenidate on whole brain intrinsic functional connectivity.
|
Hum Brain Mapp
|
2014
|
0.87
|
|
188
|
Quetiapine in the treatment of schizophrenia and related disorders.
|
Neuropsychiatr Dis Treat
|
2007
|
0.87
|
|
189
|
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.
|
J Psychiatr Res
|
2008
|
0.87
|
|
190
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.
|
World J Biol Psychiatry
|
2002
|
0.87
|
|
191
|
Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.87
|
|
192
|
Are antidepressants clinically useful? Conclusion of a decade of debate.
|
World Psychiatry
|
2014
|
0.86
|
|
193
|
State of the art: treatment of bipolar disorders.
|
CNS Neurosci Ther
|
2011
|
0.86
|
|
194
|
Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls.
|
J Psychiatr Res
|
2008
|
0.86
|
|
195
|
Functional outcomes in schizophrenia: employment status as a metric of treatment outcome.
|
Curr Psychiatry Rep
|
2012
|
0.85
|
|
196
|
Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.
|
Am J Med Genet B Neuropsychiatr Genet
|
2003
|
0.85
|
|
197
|
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
|
J Clin Psychopharmacol
|
2010
|
0.85
|
|
198
|
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
|
J Clin Psychiatry
|
2010
|
0.85
|
|
199
|
Critical trial-related criteria in acute schizophrenia studies.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.85
|
|
200
|
Antidepressants and suicidality in younger adults--is bipolar illness the missing link?
|
Acta Psychiatr Scand
|
2008
|
0.85
|
|
201
|
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
|
Int J Neuropsychopharmacol
|
2008
|
0.85
|
|
202
|
Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disorders.
|
Eur Arch Psychiatry Clin Neurosci
|
2010
|
0.85
|
|
203
|
Alterations of the early auditory evoked gamma-band response in first-degree relatives of patients with schizophrenia: hints to a new intermediate phenotype.
|
J Psychiatr Res
|
2010
|
0.85
|
|
204
|
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
|
J Clin Psychiatry
|
2002
|
0.85
|
|
205
|
Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment.
|
J Psychiatr Res
|
2009
|
0.85
|
|
206
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.
|
World J Biol Psychiatry
|
2015
|
0.85
|
|
207
|
[I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.
|
J Psychiatry Neurosci
|
2007
|
0.84
|
|
208
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
|
World J Biol Psychiatry
|
2008
|
0.84
|
|
209
|
Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
|
Depress Anxiety
|
2003
|
0.84
|
|
210
|
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
|
Eur Arch Psychiatry Clin Neurosci
|
2007
|
0.84
|
|
211
|
Repeated S-ketamine infusions in therapy resistant depression: a case series.
|
J Clin Pharmacol
|
2013
|
0.84
|
|
212
|
The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
|
World J Biol Psychiatry
|
2006
|
0.84
|
|
213
|
Internal capsule size associated with outcome in first-episode schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2009
|
0.84
|
|
214
|
Driving ability in schizophrenic patients: effects of neuroleptics.
|
Int J Psychiatry Clin Pract
|
2005
|
0.84
|
|
215
|
Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.84
|
|
216
|
Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity.
|
J Affect Disord
|
2007
|
0.83
|
|
217
|
Association between brain structure and psychometric schizotypy in healthy individuals.
|
World J Biol Psychiatry
|
2011
|
0.83
|
|
218
|
Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study.
|
Psychiatry Res
|
2008
|
0.83
|
|
219
|
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.
|
Eur Neuropsychopharmacol
|
2012
|
0.83
|
|
220
|
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
|
Psychiatry Res
|
2008
|
0.83
|
|
221
|
The Acid Sphingomyelinase Sequence Variant p.A487V Is Not Associated With Decreased Levels of Enzymatic Activity.
|
JIMD Rep
|
2012
|
0.83
|
|
222
|
Attention to emotion: auditory-evoked potentials in an emotional choice reaction task and personality traits as assessed by the NEO FFI.
|
Eur Arch Psychiatry Clin Neurosci
|
2010
|
0.83
|
|
223
|
Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment.
|
Psychopharmacology (Berl)
|
2011
|
0.83
|
|
224
|
Temperament and character of suicide attempters.
|
J Psychiatr Res
|
2007
|
0.83
|
|
225
|
Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis.
|
Hum Brain Mapp
|
2011
|
0.83
|
|
226
|
A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.
|
BMC Health Serv Res
|
2009
|
0.83
|
|
227
|
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
0.83
|
|
228
|
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
|
Psychopathology
|
2012
|
0.83
|
|
229
|
Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
|
Psychopharmacology (Berl)
|
2003
|
0.83
|
|
230
|
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.82
|
|
231
|
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
|
Schizophr Res
|
2012
|
0.82
|
|
232
|
Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
0.82
|
|
233
|
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.
|
Psychopharmacology (Berl)
|
2006
|
0.82
|
|
234
|
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.82
|
|
235
|
NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.
|
Am J Med Genet B Neuropsychiatr Genet
|
2008
|
0.82
|
|
236
|
Neuropsychological functioning in inpatients with major depression or schizophrenia.
|
BMC Psychiatry
|
2013
|
0.82
|
|
237
|
5-HT2A SNPs and the Temperament and Character Inventory.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2007
|
0.82
|
|
238
|
Evaluating the inter-episode stability of depressive mixed states.
|
J Affect Disord
|
2004
|
0.82
|
|
239
|
An early improvement threshold to predict response and remission in first-episode schizophrenia.
|
Br J Psychiatry
|
2010
|
0.82
|
|
240
|
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia.
|
Pharmacogenet Genomics
|
2009
|
0.82
|
|
241
|
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach.
|
Int J Neuropsychopharmacol
|
2012
|
0.82
|
|
242
|
Akathisia and suicidal ideation in first-episode schizophrenia.
|
J Clin Psychopharmacol
|
2012
|
0.82
|
|
243
|
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.82
|
|
244
|
Psychopathology: genetics and the stress-vulnerability hypothesis.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.81
|
|
245
|
The German Research Network on Schizophrenia--impact on the management of schizophrenia.
|
Dialogues Clin Neurosci
|
2006
|
0.81
|
|
246
|
Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior.
|
Am J Med Genet B Neuropsychiatr Genet
|
2003
|
0.81
|
|
247
|
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
|
J Clin Psychiatry
|
2010
|
0.81
|
|
248
|
The dysbindin gene in major depression: an association study.
|
Am J Med Genet B Neuropsychiatr Genet
|
2004
|
0.81
|
|
249
|
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
|
J Psychiatr Res
|
2011
|
0.81
|
|
250
|
Antipsychotic response in the first week predicts later efficacy.
|
Neuropsychobiology
|
2012
|
0.81
|
|
251
|
The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
|
World J Biol Psychiatry
|
2010
|
0.81
|
|
252
|
Creating a map of psychiatric patients based on psychopathological symptom profiles.
|
Eur Arch Psychiatry Clin Neurosci
|
2009
|
0.81
|
|
253
|
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
|
World J Biol Psychiatry
|
2010
|
0.81
|
|
254
|
Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials.
|
Int J Neuropsychopharmacol
|
2008
|
0.81
|
|
255
|
Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.81
|
|
256
|
Impulsivity is related to striatal dopamine transporter availability in healthy males.
|
Psychiatry Res
|
2012
|
0.81
|
|
257
|
Tachykinin receptor 1 variants associated with aggression in suicidal behavior.
|
Am J Med Genet B Neuropsychiatr Genet
|
2007
|
0.81
|
|
258
|
Duloxetine: a new selective and dual-acting antidepressant.
|
Expert Opin Pharmacother
|
2006
|
0.81
|
|
259
|
ABCG1 gene variants in suicidal behavior and aggression-related traits.
|
Eur Neuropsychopharmacol
|
2006
|
0.81
|
|
260
|
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.
|
J Psychiatr Res
|
2010
|
0.81
|
|
261
|
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
|
Eur Arch Psychiatry Clin Neurosci
|
2007
|
0.80
|
|
262
|
Switch to mania after slow rTMS of the right prefrontal cortex.
|
J Clin Psychiatry
|
2002
|
0.80
|
|
263
|
Prediction of symptom remission in schizophrenia during inpatient treatment.
|
World J Biol Psychiatry
|
2009
|
0.80
|
|
264
|
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
|
J Clin Psychopharmacol
|
2009
|
0.80
|
|
265
|
Evidence of agomelatine's antidepressant efficacy: the key points.
|
Int Clin Psychopharmacol
|
2007
|
0.80
|
|
266
|
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression.
|
BMC Med
|
2012
|
0.80
|
|
267
|
Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.
|
Compr Psychiatry
|
2005
|
0.80
|
|
268
|
Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.
|
J Affect Disord
|
2005
|
0.80
|
|
269
|
Does the definition of borders of the planum temporale influence the results in schizophrenia?
|
Am J Psychiatry
|
2002
|
0.80
|
|
270
|
Negative symptoms in depressed and schizophrenic patients: how do they differ?
|
J Clin Psychiatry
|
2003
|
0.80
|
|
271
|
Study design features affecting outcome in antidepressant trials.
|
J Affect Disord
|
2012
|
0.80
|
|
272
|
Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms.
|
Psychiatry Res
|
2010
|
0.80
|
|
273
|
Plasma catecholamines and selective slow wave sleep deprivation.
|
Neuropsychobiology
|
2002
|
0.80
|
|
274
|
The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study.
|
Am J Med Genet B Neuropsychiatr Genet
|
2004
|
0.80
|
|
275
|
One-year functional outcomes of naturalistically treated patients with schizophrenia.
|
Psychiatry Res
|
2012
|
0.80
|
|
276
|
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol.
|
Pharmacogenet Genomics
|
2011
|
0.79
|
|
277
|
Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease.
|
J Neurol Sci
|
2002
|
0.79
|
|
278
|
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
0.79
|
|
279
|
Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression.
|
J Psychiatr Res
|
2002
|
0.79
|
|
280
|
The free choice whether or not to respond after stimulus presentation.
|
Hum Brain Mapp
|
2009
|
0.79
|
|
281
|
Creatine protects against excitoxicity in an in vitro model of neurodegeneration.
|
PLoS One
|
2012
|
0.79
|
|
282
|
Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior.
|
Am J Med Genet B Neuropsychiatr Genet
|
2008
|
0.79
|
|
283
|
Agomelatine: The evidence for its place in the treatment of depression.
|
Core Evid
|
2010
|
0.79
|
|
284
|
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.
|
Psychiatry Res
|
2009
|
0.79
|
|
285
|
Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study.
|
Eur Arch Psychiatry Clin Neurosci
|
2009
|
0.79
|
|
286
|
Handedness and corpus callosum morphology.
|
Psychiatry Res
|
2002
|
0.79
|
|
287
|
Duloxetine in the treatment of major psychiatric and neuropathic disorders.
|
Expert Rev Neurother
|
2008
|
0.79
|
|
288
|
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode.
|
Eur Neuropsychopharmacol
|
2012
|
0.79
|
|
289
|
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.
|
World J Biol Psychiatry
|
2007
|
0.79
|
|
290
|
Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
|
BMC Med
|
2012
|
0.79
|
|
291
|
Schizotypy and behavioural adjustment and the role of neuroticism.
|
PLoS One
|
2012
|
0.79
|
|
292
|
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
|
Int Clin Psychopharmacol
|
2007
|
0.78
|
|
293
|
Emil Kraepelin's legacy: systematic clinical observation and the categorical classification of psychiatric diseases.
|
Eur Arch Psychiatry Clin Neurosci
|
2008
|
0.78
|
|
294
|
The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
|
World J Biol Psychiatry
|
2006
|
0.78
|
|
295
|
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation.
|
World J Biol Psychiatry
|
2015
|
0.78
|
|
296
|
In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature.
|
Schizophr Res
|
2007
|
0.78
|
|
297
|
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programme.
|
J Clin Psychopharmacol
|
2011
|
0.78
|
|
298
|
The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients.
|
Eur Arch Psychiatry Clin Neurosci
|
2002
|
0.78
|
|
299
|
Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits.
|
Neuropsychobiology
|
2009
|
0.78
|
|
300
|
Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments.
|
Schizophr Res
|
2004
|
0.78
|
|
301
|
Interference control in adult ADHD: no evidence for interference control deficits if response speed is controlled by delta plots.
|
Acta Psychol (Amst)
|
2013
|
0.77
|
|
302
|
Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
|
Neuropsychobiology
|
2003
|
0.77
|
|
303
|
The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.
|
J Clin Psychiatry
|
2008
|
0.77
|
|
304
|
Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.
|
PLoS One
|
2013
|
0.77
|
|
305
|
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.
|
Psychiatr Q
|
2012
|
0.77
|
|
306
|
Cholinergic impact on neuroplasticity drives muscarinic M1 receptor mediated differentiation into neurons.
|
World J Biol Psychiatry
|
2011
|
0.77
|
|
307
|
White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2008
|
0.77
|
|
308
|
Understanding mental disorders from neuronal networks to glial cells and proteomics.
|
Eur Arch Psychiatry Clin Neurosci
|
2010
|
0.77
|
|
309
|
World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care.
|
Int J Psychiatry Clin Pract
|
2014
|
0.77
|
|
310
|
Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism.
|
Clin EEG Neurosci
|
2007
|
0.77
|
|
311
|
Disentangling the adult attention-deficit hyperactivity disorder endophenotype: parametric measurement of attention.
|
J Abnorm Psychol
|
2011
|
0.77
|
|
312
|
No association of a set of candidate genes on haloperidol side effects.
|
PLoS One
|
2012
|
0.77
|
|
313
|
The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
|
Eur Arch Psychiatry Clin Neurosci
|
2009
|
0.77
|
|
314
|
Is evaluation of humorous stimuli associated with frontal cortex morphology? A pilot study using facial micro-movement analysis and MRI.
|
Cortex
|
2010
|
0.77
|
|
315
|
Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.
|
J Affect Disord
|
2004
|
0.77
|
|
316
|
Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
0.77
|
|
317
|
Transcranial magnetic stimulation for panic.
|
Am J Psychiatry
|
2002
|
0.77
|
|
318
|
Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression.
|
Am J Med Genet
|
2002
|
0.77
|
|
319
|
Are placebo-controlled studies required in order to prove efficacy of antidepressants?
|
World J Biol Psychiatry
|
2005
|
0.77
|
|
320
|
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
|
World J Biol Psychiatry
|
2011
|
0.77
|
|
321
|
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
|
Eur Arch Psychiatry Clin Neurosci
|
2003
|
0.77
|
|
322
|
A case of persistent retrograde amnesia following a dissociative fugue: neuropsychological and neurofunctional underpinnings of loss of autobiographical memory and self-awareness.
|
Neuropsychologia
|
2008
|
0.77
|
|
323
|
No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2002
|
0.77
|
|
324
|
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
|
Psychopharmacology (Berl)
|
2002
|
0.77
|
|
325
|
Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study.
|
J Psychiatr Res
|
2003
|
0.77
|
|
326
|
Reception of Kraepelin's ideas 1900-1960.
|
Psychiatry Clin Neurosci
|
2011
|
0.77
|
|
327
|
Cardiovascular disease and diabetes in people with severe mental illness.
|
Rev Psiquiatr Salud Ment
|
2009
|
0.77
|
|
328
|
Intact emotion-cognition interaction in schizophrenia patients and first-degree relatives: evidence from an emotional antisaccade task.
|
Brain Cogn
|
2013
|
0.76
|
|
329
|
The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice.
|
World J Biol Psychiatry
|
2011
|
0.76
|
|
330
|
Meta-analyses: a method to maximise the evidence from clinical studies?
|
Eur Arch Psychiatry Clin Neurosci
|
2010
|
0.76
|
|
331
|
Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.
|
Psychopharmacology (Berl)
|
2010
|
0.76
|
|
332
|
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
|
World J Biol Psychiatry
|
2010
|
0.76
|
|
333
|
Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
|
Int J Neuropsychopharmacol
|
2006
|
0.76
|
|
334
|
Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
|
Pharmacopsychiatry
|
2004
|
0.76
|
|
335
|
Effects of different antidepressant treatments on the core of depression.
|
Dialogues Clin Neurosci
|
2008
|
0.76
|
|
336
|
Major depression is common in people over the age of 50, particularly in those at socioeconomic disadvantage, or with poor physical health and previous depressive symptoms.
|
Evid Based Ment Health
|
2005
|
0.76
|
|
337
|
Estrogen receptor gene 1 variants are not associated with suicidal behavior.
|
Psychiatry Res
|
2008
|
0.76
|
|
338
|
Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?
|
CNS Drugs
|
2003
|
0.76
|
|
339
|
Investigation of a possible diencephalic pathology in schizophrenia.
|
Psychiatry Res
|
2002
|
0.76
|
|
340
|
The CNR1 gene in depression and schizophrenia - is there an association with early improvement and response?
|
Psychiatry Res
|
2012
|
0.76
|
|
341
|
[Are placebo controlled studies on the proof of effectiveness of antidepressants necessary?].
|
Nervenarzt
|
2004
|
0.76
|
|
342
|
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
|
Neuropsychopharmacology
|
2004
|
0.76
|
|
343
|
Is there a need for a new psychiatric classification at the current state of knowledge?
|
World J Biol Psychiatry
|
2008
|
0.76
|
|
344
|
On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses.
|
Psychopathology
|
2003
|
0.75
|
|
345
|
Metaanalyses - highest level of empirical evidence?
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
0.75
|
|
346
|
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years.
|
Evid Based Ment Health
|
2010
|
0.75
|
|
347
|
Empathy without borders? Cross-cultural heart and mind-reading in first-year medical students.
|
Ethiop J Health Sci
|
2013
|
0.75
|
|
348
|
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
|
World J Biol Psychiatry
|
2006
|
0.75
|
|
349
|
Evidence of depressive mixed states.
|
Am J Psychiatry
|
2005
|
0.75
|
|
350
|
Reply to the letter to the editor by George et Al.
|
World J Biol Psychiatry
|
2014
|
0.75
|
|
351
|
Classification of functional psychoses and its implication for prognosis: comparison between ICD-10 and DSM-IV.
|
Psychopathology
|
2004
|
0.75
|
|
352
|
From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.75
|
|
353
|
Biomarkers and neurobiology of schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2012
|
0.75
|
|
354
|
Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects?
|
Am J Med Genet B Neuropsychiatr Genet
|
2009
|
0.75
|
|
355
|
In people taking antidepressants, suicidal behaviour is less common when they are taking them than in unexposed periods.
|
Evid Based Ment Health
|
2011
|
0.75
|
|
356
|
Correspondence (reply): In reply.
|
Dtsch Arztebl Int
|
2013
|
0.75
|
|
357
|
Sleep, hypothalamus, and stigma.
|
Eur Arch Psychiatry Clin Neurosci
|
2010
|
0.75
|
|
358
|
[Priority for atypical antipsychotics--comments on the article by Dose M. Priority for Atypicals? Current studies clarify some aspects. Psychiat Prax 2007; 34:46-49].
|
Psychiatr Prax
|
2007
|
0.75
|
|
359
|
NCAM1, TACR1 and NOS genes and temperament: a study on suicide attempters and controls.
|
Neuropsychobiology
|
2011
|
0.75
|
|
360
|
Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy.
|
Int J Psychiatry Clin Pract
|
2015
|
0.75
|
|
361
|
Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits.
|
Psychiatry Res
|
2010
|
0.75
|
|
362
|
Summer birth and deficit schizophrenia.
|
Am J Psychiatry
|
2003
|
0.75
|
|
363
|
Dysequilibrium of neuronal proliferation and apoptosis in a pharmacological animal model of psychosis.
|
Methods
|
2012
|
0.75
|
|
364
|
Access to the world journal of biological psychiatry.
|
World J Biol Psychiatry
|
2004
|
0.75
|
|
365
|
Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
|
Eur Arch Psychiatry Clin Neurosci
|
2002
|
0.75
|
|
366
|
Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.
|
Int Clin Psychopharmacol
|
2017
|
0.75
|
|
367
|
[123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.
|
Eur Arch Psychiatry Clin Neurosci
|
2007
|
0.75
|
|
368
|
[The role of the family physician in the treatment concept of schizophrenic disorders].
|
MMW Fortschr Med
|
2006
|
0.75
|
|
369
|
[Bipolar disorders: update on current treatment options].
|
MMW Fortschr Med
|
2010
|
0.75
|
|
370
|
Association study of a SNP coding for a M129V substitution in the prion protein in schizophrenia.
|
Schizophr Res
|
2003
|
0.75
|
|
371
|
Do effectiveness studies tell us the real truth?
|
World J Biol Psychiatry
|
2007
|
0.75
|
|
372
|
A continuing success story.
|
World J Biol Psychiatry
|
2005
|
0.75
|
|
373
|
[Therapeutic decisions based on meta analyses].
|
Psychiatr Prax
|
2008
|
0.75
|
|
374
|
Is lithium sill the gold standard in the treatment of bipolar disorders?
|
Eur Arch Psychiatry Clin Neurosci
|
2003
|
0.75
|
|
375
|
[Antidepressants for mild depressive disorders].
|
Psychiatr Prax
|
2011
|
0.75
|
|
376
|
The best next drug in the course of generalized anxiety disorders: the "PN-GAD-algorithm".
|
Int J Psychiatry Clin Pract
|
2013
|
0.75
|
|
377
|
SSRIs: are the accusations justified?
|
World J Biol Psychiatry
|
2004
|
0.75
|
|
378
|
How to grade categories of evidence.
|
World J Biol Psychiatry
|
2008
|
0.75
|
|
379
|
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
0.75
|
|
380
|
[Sleep disorders in major psychiatric diseases].
|
MMW Fortschr Med
|
2012
|
0.75
|
|
381
|
Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS.
|
Suppl Clin Neurophysiol
|
2003
|
0.75
|
|
382
|
Targets of antidementive therapy: drugs with a specific pharmacological mechanism of action.
|
Curr Pharm Des
|
2004
|
0.75
|
|
383
|
Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine.
|
J Clin Pharmacol
|
2013
|
0.75
|
|
384
|
The 26(th) Danube Symposium of Psychiatry: Psychiatry - ready for the future?
|
Psychiatr Danub
|
2016
|
0.75
|
|
385
|
Disturbance in the well-being of a patient with acne: suggestions for anticipation and detection.
|
Acta Derm Venereol
|
2005
|
0.75
|
|
386
|
[Schizophrenic patients in the family practice].
|
MMW Fortschr Med
|
2007
|
0.75
|